dc.contributor.author | Ozden, Ferhat | |
dc.contributor.author | Onal, Bülent | |
dc.contributor.author | Aki, Hilal | |
dc.contributor.author | Durak, Haydar | |
dc.contributor.author | Saygin, Caner | |
dc.contributor.author | Uzunaslan, Didem | |
dc.date.accessioned | 2021-03-04T13:12:46Z | |
dc.date.available | 2021-03-04T13:12:46Z | |
dc.date.issued | 2013 | |
dc.identifier.citation | Ozden F., Saygin C., Uzunaslan D., Onal B., Durak H., Aki H., "Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival", JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, cilt.139, sa.8, ss.1373-1382, 2013 | |
dc.identifier.issn | 0171-5216 | |
dc.identifier.other | av_7b328343-952c-48e7-b66a-66edf0fa1865 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/84368 | |
dc.identifier.uri | https://doi.org/10.1007/s00432-013-1453-x | |
dc.description.abstract | Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) participate in tumorigenesis, and their association with disease outcome is highly controversial. The present study investigates the influence of MMP-1, MMP-9 and TIMP-2 on different clinicopathologic variables and disease-free survival (DFS) of patients with prostate carcinoma. | |
dc.language.iso | eng | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Onkoloji | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | ONKOLOJİ | |
dc.title | Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 139 | |
dc.identifier.issue | 8 | |
dc.identifier.startpage | 1373 | |
dc.identifier.endpage | 1382 | |
dc.contributor.firstauthorID | 59184 | |